Elon Musk's company, Neuralink, has announced that it has received FDA approval to research brain implants in humans
The company has not elaborated on the research objectives, noting only that participant recruitment has not yet begun and more detailed information will be available in due course
Elon Musk's brain implant production company Neuralink has announced that the US Food and Drug Administration (FDA) has given the green light to the first clinical trial in humans, marking a significant milestone following previous attempts to gain approval.
This news was reported by Reuters.
FDA approval "is an important first step that will one day allow our technology to help many people," Neuralink tweeted.
Musk believes that brain implants could cure a range of diseases, including obesity, autism, depression, and schizophrenia, as well as enabling web browsing and telepathy.
At least four times since 2019, Musk predicted that Neuralink would begin human trials. However, the company only submitted its FDA approval application in early 2022, and it was rejected by the agency.
Background. Mind previously reported that Musk's company Neuralink was seeking a partner for human brain implant trials.
If you have read this article to the end, we hope that means it was useful for you.
We work to ensure that our journalistic and analytical work is of high quality, and we strive to perform it as competently as possible. This also requires financial independence. Support us for only UAH 196 per month.
Become a Mind subscriber for just USD 5 per month and support the development of independent business journalism!
You can unsubscribe at any time in your LIQPAY account or by sending us an email: [email protected]
